BioLineRx (BLRX) Common Equity (2010 - 2026)
BioLineRx's Common Equity was $16.62 million in the quarter ended Jun 30, 2026, down 17.2% from $20.07 million a year earlier and down 20.2% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Common Equity (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, Common Equity at BioLineRx came in at $23.35 million, up 73.4% from the prior year.
- Common Equity shows a five-year compound annual growth rate of 1.2% (years ended Dec 2020 to Dec 2025).
- In earlier years, Common Equity was $13.46 million in the year ended Dec 31, 2024 (+1.8%), $13.22 million in the year ended Dec 31, 2023 (-74.0%), $50.84 million in the year ended Dec 31, 2022 (-25.3%) and $68.09 million in the year ended Dec 31, 2021 (+209.1%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Common Equity since the quarter ended Dec 31, 2024.
- Compared with a year earlier, Common Equity was higher in five of the last eight quarters, with growth averaging 32.0%.
- The best year-over-year quarter for Common Equity over five years was the quarter ended Dec 31, 2021 (growth of 209.1%); the worst was the quarter ended Sep 30, 2023 (a decline of 76.3%).
- Per Business Quant data, BLRX's Common Equity in the three quarters before the quarter ended Jun 30, 2026 was $20.84 million (quarter ended Mar 31, 2026), $23.35 million (quarter ended Dec 31, 2025) and $19.53 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | 16.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.62 Mn |
| Mar 31, 2026 | 20.84 Mn |
| Dec 31, 2025 | 23.35 Mn |
| Sep 30, 2025 | 19.53 Mn |
| Jun 30, 2025 | 20.07 Mn |
| Mar 31, 2025 | 20.86 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 8.51 Mn |
| Jun 30, 2024 | 13.98 Mn |
| Mar 31, 2024 | 13.06 Mn |
| Dec 31, 2023 | 13.22 Mn |
| Sep 30, 2023 | 13.13 Mn |
| Jun 30, 2023 | 21.05 Mn |
| Mar 31, 2023 | 39.11 Mn |
| Dec 31, 2022 | 50.84 Mn |
| Sep 30, 2022 | 55.52 Mn |
| Jun 30, 2022 | 56.57 Mn |
| Mar 31, 2022 | 63.41 Mn |
| Dec 31, 2021 | 68.09 Mn |
| Sep 30, 2021 | 70.90 Mn |
API Access
BioLineRx Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();